[Clinical features of the attentional deficit and hyperactivity disorder in epilepsy]

Viviana Venegas1,2, José María De Pablo1, Carmen Olbrich1

  • 1Instituto de Neurocirugía Asenjo, Chile.

Medicina
|March 10, 2020
PubMed

Insights

Epilepsy and attention deficit hyperactivity disorder (ADHD) frequently co-occur in children, often linked by cognitive deficits. Early suspicion, cognitive assessment, and multimodal treatment, including psychostimulants, are crucial for managing these complex conditions.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders

Background:

  • Epilepsy and attention deficit hyperactivity disorder (ADHD) are common pediatric conditions with complex associations.
  • Psychiatric comorbidities frequently overlap between epilepsy and ADHD.

Purpose of the Study:

  • To review the association between epilepsy and ADHD in children.
  • To discuss risk factors, diagnostic approaches, and treatment strategies for co-occurring epilepsy and ADHD.

Main Methods:

  • Literature review focusing on the relationship between epilepsy and ADHD.
  • Analysis of epidemiological data, risk factors, and diagnostic criteria.
  • Evaluation of treatment options and their impact on quality of life.

Main Results:

  • ADHD and epilepsy affect both genders equally, with the inattentive subtype predominant.
  • Cognitive deficits increase the risk of ADHD in epilepsy patients; network dysfunction is implicated.
  • Psychostimulants are safe for treating ADHD in patients with or without epilepsy.

Conclusions:

  • Diagnosis of ADHD in epilepsy patients should be based on clinical suspicion, cognitive assessments, and validated instruments.
  • Multimodal treatment and specialized team support are recommended to improve outcomes.
  • Untreated ADHD in epilepsy can lead to persistent negative academic, social, and emotional consequences.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
659
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
806
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
542
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
738